| 產品名稱 | ATB 346 |
| 產品貨號 | Axon 2288 CAS [1226895-20-0] MF C21H19NO3SMW 365.45 Purity: 99% Soluble in DMSO Description Orally active hydrogen sulfide-releasing cyclooxygenase inhibitor and a derivative of Naproxen (significantly reduced exudate leukocyte and PGE2 levels at 30 μmol/kg oral administration). ATB-346 exhibits anti-inflammatory properties similar to naproxen.In a mouse airpouch model, ATB-346 suppressed cyclooxygenase-2 activity and inhibited leukocyte infiltration more effectively than naproxen but with substantially reduced gastrointestinal toxicity (100-fold safer than naproxen). KEYWORDS:?ATB 346 | supplier | COX inhibitor; H2S-releasing compound | ATB346 | CAS [1226895-20-0] | Fatty acid (Arachidonic acid) | COX | Inhibitor | cyclooxygenase | Naproxen | anti-inflammatory | leukocyte infiltration |
| 產品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產品規(guī)格 | |
| 產品品牌 | axonmedchem |
| 產品概述 | |
| 產品詳情 |
ATB 346Axon 2288 CAS [1226895-20-0] MF C21H19NO3S
DescriptionOrally active hydrogen sulfide-releasing cyclooxygenase inhibitor and a derivative of Naproxen (significantly reduced exudate leukocyte and PGE2 levels at 30 μmol/kg oral administration). ATB-346 exhibits anti-inflammatory properties similar to naproxen.In a mouse airpouch model, ATB-346 suppressed cyclooxygenase-2 activity and inhibited leukocyte infiltration more effectively than naproxen but with substantially reduced gastrointestinal toxicity (100-fold safer than naproxen). KEYWORDS:?ATB 346 | supplier | COX inhibitor; H2S-releasing compound | ATB346 | CAS [1226895-20-0] | Fatty acid (Arachidonic acid) | COX | Inhibitor | cyclooxygenase | Naproxen | anti-inflammatory | leukocyte infiltration
Orally active hydrogen sulfide-releasing cyclooxygenase inhibitor
Chemical name4-Carbamothioylphenyl 2-(6-methoxynaphthalen-2-yl)propanoate Parent CAS No.[1226895-20-0] |
| 產品資料 |
